 the first nine months earn 18% to 327 million .png)
Shandong Luoxin Pharmacy Stock (08058) announced at the end of September 2011 only nine months results, profit attributable to shareholders for the period increased 17.97% to 3.27 billion yuan, profit of 53.71 cents per share, non-interim rates; In addition, as end of September, just three months performance, profit attributable to shareholders for the period 96,553,000 yuan, the annual growth of 12.91%. Stock and index information provided by the Megahub and AASTOCKS. ...Luoxin Pharma (08058) the first nine months earn 18% to 327 million
Monday, October 31, 2011
Luoxin Pharma (08058) the first nine months earn 18% to 327 million
Shandong Luoxin Pharmacy Stock (08058) announced at the end of September 2011 only nine months results, profit attributable to shareholders for the period increased 17.97% to 3.27 billion yuan, profit of 53.71 cents per share, non-interim rates; In addition, as end of September, just three months performance, profit attributable to shareholders for the period 96,553,000 yuan, the annual growth of 12.91%. Stock and index information provided by the Megahub and AASTOCKS. ...Luoxin Pharma (08058) the first nine months earn 18% to 327 million
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment